Agios Pharmaceuticals gets PYRUKYND FDA approval for hemolytic anemia

Agios Pharmaceuticals has secured approval for PYRUKYND (mitapivat) from the US Food and Drug Administration (FDA) for the treatment of hemolytic anemia in adult patients ... Read More